2nd Quarter - Amendment
FORBES-TATE for GILEAD SCIENCES, INC.
Firm
Client
Income
$90,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 14, 2024 | $80,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Jul 17, 2024 | $90,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to healthcare, including improving patient access to advanced immunology therapies; Issues related to policies affecting biopharma products pricing, coverage, and access in Medicare and Medicaid; Issues related to funding for HIV and HCV screening, linkage to care, and treatment; Issues related to breast cancer screening.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| KRISTINA DUNKLIN | — |
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
| BARRETT THORNHILL | — |
| DERRICK M WHITE | — |
| MICHAEL ALEXANDER WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.